Cited by 72Liver physiology and pathologyTissue Engineering and Regenerative Medicine3D Printing in Biomedical Research

Next-Generation Liver Medicine Using Organoid Models

Open access
Akbari, Soheil, Arslan, Nur, Senturk, Serif, Erdal, Esra·2019·Frontiers in Cell and Developmental Biology

Abstract

“Liver medicine” refers to all diagnostic and treatment strategies of diseases and conditions that cause liver failure directly or indirectly. Despite significant advances in the field of liver medicine in recent years, improved tools are needed to efficiently define pathophysiology of liver diseases and provide effective therapeutic options to patients. Recently, organoid technology has been established as the state-of-the-art cell culture tool to study human biology in health and disease. In general, organoids are simplified three dimensional (3D) mini-organ structures that can be grown in a 3D matrix where the structural and functional aspects of real organs are efficiently recapitulated. The generation of organoids is facilitated by exogenous factors that regulate multiple signaling pathways and promote the self-renewal, proliferation, and differentiation of the cells to promote spontaneous self-organization and tissue-specific organogenesis. Newly established protocols suggest that liver-specific organoids can be derived from either pluripotent stem cells or liver specific stem/progenitor cells. Today, robust and long-term cultures of organoids with the closest physiology to in vivo liver, in terms of cellular composition and function, open a new era in studying and understanding the disease pathology as well as high-throughput drug screening. Of note, these next-generation cell culture systems carry an immense potential to be further improved by genome editing and bioengineering technologies to foster the development of patient-specific therapeutic options for clinical applications. Here, we will discuss recent advances and challenges on the generation of human liver organoids and highlight emerging concepts on their potential applications in liver medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcell.2019.00345

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Three-dimensional cell cultures, especially organoids, have been proposed for mimicking the architecture and genetic expression of native human liver tissue.

    “To overcome the limitations of these 2D in vitro models, three-dimensional (3D) cell cultures-especially organoids-have been proposed for mimicking the architecture and genetic expression of native human liver tissue (Akbari et al., 2019;Sorrentino et al., 2020).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Akbari, S., Arslan, N., Senturk, S., & Erdal, E.
Affiliations
  • Izmir Biomedicine and Genome Center (TR)
  • Dokuz Eylül University (TR)
Corresponding author
Erdal, Esra
Venue
Frontiers in Cell and Developmental Biology
Published
2019-12-20
Volume
7
Pages
345-345
ISSN
2296-634X (ISSN-L)
OpenAlex
W2994771578
Cited by
72
References
137
Citations by year
2026: 4 · 2025: 8 · 2024: 10 · 2023: 15 · 2022: 6 · 2021: 19 · 2020: 9
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (115S465)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
liver organoids, liver disease, liver failure, pluripotent stem cells, 3D cell culture, organogenesis, high-throughput drug screening, genome editing, bioengineering, patient-specific therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review